Marino Stram & Associates’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,931
Closed -$280K 155
2022
Q3
$280K Buy
5,931
+10
+0.2% +$519 0.1% 118
2022
Q2
$299K Buy
5,921
+5
+0.1% +$273 0.1% 119
2022
Q1
$361K Buy
5,916
+18
+0.3% +$1.07K 0.11% 116
2021
Q4
$388K Sell
5,898
-283
-5% -$18.1K 0.12% 111
2021
Q3
$388K Buy
+6,181
New +$394K 0.13% 105
2021
Q2
Sell
-5,370
Closed -$296K 269
2021
Q1
$296K Buy
+5,370
New +$298K 0.12% 110

Other funds holding IHI

Marino Stram & Associates's IHI Position: Q4 2022 in Review

Marino Stram & Associates sold out of iShares US Medical Devices ETF (IHI) in Q4 2022, closing a stake of 5,931 shares — an estimated $280K sold.

Marino Stram & Associates first reported a position in IHI in Q1 2021 and held it in 6 quarters. The position peaked at $388K in Q4 2021. 577 funds tracked by Wall St. Rank hold IHI as of Q4 2022.

  • Marino Stram & Associates reported no remaining iShares US Medical Devices ETF position as of Q4 2022 after selling out during the quarter.
  • Marino Stram & Associates sold 5,931 iShares US Medical Devices ETF shares in Q4 2022, an estimated $280K.
  • Marino Stram & Associates first reported a position in iShares US Medical Devices ETF in Q1 2021 and held it in 6 quarters.
  • Marino Stram & Associates's iShares US Medical Devices ETF position peaked at $388K in Q4 2021.
  • 577 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2022.

Based on Marino Stram & Associates's 13F filing for Q4 2022, filed 19 Jan 2023.